Concepedia

Hella Kohlhof

HK

23

Publications

824

Citations

15

H-Index

2003

Active since

Affiliations

Max Planck Institute of Biochemistry(Current)

Urologische Klinik München

Ludwig-Maximilians-Universität München

Monash University

University of Göttingen

Hella Kohlhof is an author at Max Planck Institute of Biochemistry specializing in medicine, molecular pharmacology, and pharmacology.

ORCID

Top concepts

Publications per year

2003–2024

23

Publications

23

Notch Signaling Induces Multilineage Myeloid Differentiation and Up-Regulates PU.1 Expression

Timm Schroeder, Hella Kohlhof, Nikolaus Rieber et al. · The Journal of Immunology · 2003 · 110 citations · Full text

Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner

Vivek Kumar Mishra, Florian Wegwitz, Robyn Laura Kosinsky et al. · Nucleic Acids Research · 2017 · 91 citations · Full text

, , +22

Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis

Andreas Muehler, Evelyn Peelen, Hella Kohlhof et al. · Multiple Sclerosis and Related Disorders · 2020 · 62 citations

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro

Friedrich Hahn, Christina Wangen, Sigrun Häge et al. · Viruses · 2020 · 62 citations · Full text

Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines

Maria Pinkerneil, Michèle J. Hoffmann, Hella Kohlhof et al. · Targeted Oncology · 2016 · 57 citations · Full text

Rows per page

1–5 of 23